학술논문
Carfilzomib-Lenalidomide-Dexamethasone (KRd) Vs. Lenalidomide-Dexamethasone (Rd) in Newly Diagnosed Fit or Intermediate-Fit Multiple Myeloma Patients Not Eligible for Autologous Stem-Cell Transplantation (Phase III EMN20 Trial): Analysis of Sustained Undetectable Minimal Residual Disease (MRD)
Document Type
Journal
Author
Bringhen, Sara; Antonioli, Elisabetta; Gamberi, Barbara; Bruno, Benedetto; Derudas, Daniele; Tosi, Patrizia; Fazio, Francesca; Mazza, Rita; Ronconi, Sonia; Corradini, Paolo; Lotti, Flavia; Cellini, Claudia; Falcone, Antonietta Pia; Galieni, Piero; Ria, Roberto; Belotti, Angelo; Mannina, Donato; Cafro, Anna Maria; Cangialosi, Clotilde; Vincelli, Iolanda Donatella; Lombardo, Alessandra; Larocca, Alessandra; Boccadoro, Mario; D'Agostino, Mattia
Source
Subject
Language
English
ISSN
15280020